Efficacy and Safety of Apremilast in Patients With Genital Psoriasis: Results From the Phase 3, Randomized, Placebo-Controlled, Double-Blind DISCREET Study. J of Skin 2023, 7 (2), s110. https://doi.org/10.25251/skin.7.supp.110.